CIK 0001382101
- Non-accelerated filer
- Smaller reporting company
SUTRO BIOPHARMA, INC.
Sign in to watch- Ticker
- STRO
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 452441988
- Phone
- +1 650-392-8412
- Business address
- 111 OYSTER POINT BLVD., SOUTH SAN FRANCISCO, CA, 94080
- Former names
- SUTRO BIOPHARMA INC, Fundamental Applied Biology Inc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-09-18 | Gerber Hans-Peter Chief Scientific Officer | Grant or award · Restricted Stock Unit (RSU) | +150,000 | 150,000 | ||
| 2023-08-28 | Shtylla Brunilda Chief Business Officer | Sale | −15,428 | $4.71 | $73K | 0 |
| 2023-08-25 | Shtylla Brunilda Chief Business Officer | Sale | −11,613 | $4.59 | $53K | 12,928 |
| 2023-08-09 | Chung Jane Chief Commercial Officer | Exercise or conversion | +18,750 | 38,181 | ||
| 2023-08-09 | Chung Jane Chief Commercial Officer | Shares withheld for taxes | −6,483 | $4.22 | $27K | 31,698 |
| 2023-08-09 | Chung Jane Chief Commercial Officer | Exercise or conversion · Restricted Stock Unit (RSU) | −18,750 | 37,500 | ||
| 2023-07-12 | Vasquez Nicki Chief Port. Strat & Alnce Ofcr | Exercise or conversion | +3,250 | 26,111 | ||
| 2023-07-12 | Vasquez Nicki Chief Port. Strat & Alnce Ofcr | Shares withheld for taxes | −1,123 | $4.70 | $5K | 24,988 |
| 2023-07-12 | Vasquez Nicki Chief Port. Strat & Alnce Ofcr | Exercise or conversion · Restricted Stock Unit (RSU) | −3,250 | 6,500 | ||
| 2023-06-27 | Petree Daniel H Director | Gift | −18,409 | 3,856 | ||
| 2023-06-27 | Petree Daniel H Director | Gift | +18,409 | 18,601 | ||
| 2023-06-08 | Hunter Heidi Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2023-06-08 | Wigginton Jon Marc Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2023-06-08 | Petree Daniel H Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2023-06-08 | PANEK JAMES P Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2023-06-08 | MATSUI CONNIE Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2023-06-08 | Lobacki Joseph M Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2023-06-08 | Freund John Gordon Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2023-06-08 | Dybbs Michael Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2023-05-01 | Srinivasan Venkatesh Chief Tech Op Officer | Grant or award · Stock Option (right to buy Common Stock) | +7,500 | 7,500 |
Page 15 of 27 · 535 trades